Journal of the National Cancer Institute (JNCI) |
Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma |
mai. 15 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |
Journal of the National Cancer Institute (JNCI) |
Analysis of Postoperative Recurrence in Stage I–III Midgut Neuroendocrine Tumors |
mar. 18 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome |
juin. 15 |
3 ♥ |
Cancer colorectal (CCR), Génétique |
Journal of the National Cancer Institute (JNCI) |
BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis |
nov. 18 |
1 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis |
aoû. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Effects of Nutrition Intervention on Total and Cancer Mortality: 25-Year Post-trial Follow-up of the 5.25-Year Linxian Nutrition Intervention Trial |
nov. 18 |
1 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
Sweetened Beverage Consumption and Risk of Biliary Tract and Gallbladder Cancer in a Prospective Study |
juin. 16 |
2 ♥ |
Cancers autres |
Journal of the National Cancer Institute (JNCI) |
The Heterogeneity Between Lynch-Associated and Sporadic MMR Deficiency in Colorectal Cancers |
sep. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer |
mai. 17 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Incidence of Diabetes in Colorectal Cancer Survivors |
juin. 16 |
2 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands’ Susceptibility Gene Mutation Status |
mar. 19 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Influence of Statins and Cholesterol on Mortality Among Patients With Pancreatic Cancer |
mai. 17 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer |
aoû. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial |
nov. 15 |
1 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
Design and Validation of the GI-NEC Score to Prognosticate Overall Survival in Patients With High-Grade Gastrointestinal Neuroendocrine Carcinomas |
Jan. 17 |
|
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Colorectal Cancer Incidence Patterns in the United States, 1974–2013 |
aoû. 17 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
The Changing Face of Noncardia Gastric Cancer Incidence Among US Non-Hispanic Whites |
juin. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer |
avr. 19 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer |
avr. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Tumor-Infiltrating Lymphocytes, Crohn's-Like Lymphoid Reaction, and Survival From Colorectal Cancer |
mai. 16 |
2 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
Coffee Consumption and Risk of Gallbladder Cancer in a Prospective Study |
mar. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy |
mai. 18 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Overall Survival Prediction and Usefulness of Second-Line Chemotherapy in Advanced Pancreatic Adenocarcinoma |
oct. 17 |
3 ♥ |
Carcinome hépatocellaire (CHC) |
Journal of the National Cancer Institute (JNCI) |
Use of Positron Emission Tomography to Detect Recurrence and Associations With Survival in Patients With Lung and Esophageal Cancers |
juil. 16 |
3 ♥ |
Cancers autres (hors CCR et CHC), Œsophage/Estomac, Endoscopie/Imagerie |
Journal of the National Cancer Institute (JNCI) |
Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial |
aoû. 16 |
2 ♥ |
Cancer colorectal (CCR) |